Health-care companies rose as traders sought out defensive sectors less sensitive to tariff impacts.
Shares of vaccine makers tumbled after a leading Food and Drug Administration vaccine regulator quit after clashing with Department of Health and Human Services head Robert F. Kennedy Jr.
Moderna, Novavax and others fell after Peter Marks, who led the FDA's Center for Biologics Evaluation and Research, resigned. Isomorphic Labs raised $600 million in its first external funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
March 31, 2025 17:19 ET (21:19 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.